Sveriges mest populära poddar
Talking Points
Vetenskap

Episode 84: A Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor in STEMI

7 min•18 december 2019
C. Michael Gibson and Dean Kereiakes discuss the first human use of RUC-4, designed for STEMI point-of-care treatment.

Fler avsnitt av Talking Points

Visa alla avsnitt av Talking Points
The PROCTOR Trial
•9 min
The SELUTION DeNovo Trial
•5 min
The VESALIUS-CV Trial
•7 min
The META-AF Trial
•5 min
Evolution of Pharmacotherapy in STEMI
•8 min
The CorCMR Trial
•6 min
The TUXEDO-2 Trial
•4 min
The FLOW Trial
•6 min
The 2024 ESC CCS Guidelines
•16 min
The My Heart Your Heart Trial
•6 min

Talking Points med TCTMD finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.